Catalyst Pharmaceuticals submits NDS to Health Canada for Agamree – TipRanksBy News Today © / April 8, 2025 Catalyst Pharmaceuticals submits NDS to Health Canada for Agamree TipRanks “canada health” – Google NewsFacebook0Twitter0Pinterest0Linkedin0Tumblr0StumbleuponVKontakte0Reddit0Delicious0Weibo0Xing0Print0E-mail0Whatsapp0Bufferapp0Evernote0GetPocket0Yahoo Mail0GMail0Blogger0Viber0Telegram0Flipboard0Skype0Messenger0LiveJournal0
New Drug Submission for AGAMREE® (vamorolone) Accepted for Priority Review by Health Canada for the Treatment of Duchenne Muscular Dystrophy – PR NewswireHealth & Medicine North America | April 8, 2025
‘No guidance and no leadership’: chaos and confusion at CDC after mass firings – The GuardianHealth & Medicine North America | April 8, 2025
